Literature DB >> 33467040

The Neuromelanin Paradox and Its Dual Role in Oxidative Stress and Neurodegeneration.

Alexandra Moreno-García1,2, Alejandra Kun3,4, Miguel Calero1,2,5, Olga Calero1,2.   

Abstract

Aging is associated with an increasing dysfunction of key brain homeostasis mechanisms and represents the main risk factor across most neurodegenerative disorders. However, the degree of dysregulation and the affectation of specific pathways set apart normal aging from neurodegenerative disorders. In particular, the neuronal metabolism of catecholaminergic neurotransmitters appears to be a specifically sensitive pathway that is affected in different neurodegenerations. In humans, catecholaminergic neurons are characterized by an age-related accumulation of neuromelanin (NM), rendering the soma of the neurons black. This intracellular NM appears to serve as a very efficient quencher for toxic molecules. However, when a neuron degenerates, NM is released together with its load (many undegraded cellular components, transition metals, lipids, xenobiotics) contributing to initiate and worsen an eventual immune response, exacerbating the oxidative stress, ultimately leading to the neurodegenerative process. This review focuses on the analysis of the role of NM in normal aging and neurodegeneration related to its capabilities as an antioxidant and scavenging of harmful molecules, versus its involvement in oxidative stress and aberrant immune response, depending on NM saturation state and its extracellular release.

Entities:  

Keywords:  immune response; neurodegeneration; neuromelanin (NM); oxidative stress; reactive oxygen species (ROS)

Year:  2021        PMID: 33467040      PMCID: PMC7829956          DOI: 10.3390/antiox10010124

Source DB:  PubMed          Journal:  Antioxidants (Basel)        ISSN: 2076-3921


  180 in total

Review 1.  Cu and Zn interactions with Aβ peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers.

Authors:  Monika Rana; Anuj Kumar Sharma
Journal:  Metallomics       Date:  2019-01-23       Impact factor: 4.526

Review 2.  Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration.

Authors:  Shashank Masaldan; Ashley I Bush; David Devos; Anne Sophie Rolland; Caroline Moreau
Journal:  Free Radic Biol Med       Date:  2018-09-25       Impact factor: 7.376

Review 3.  Age-related macular degeneration (AMD): Alzheimer's disease in the eye?

Authors:  Kai Kaarniranta; Antero Salminen; Annakaisa Haapasalo; Hilkka Soininen; Mikko Hiltunen
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 4.  Neuronal vulnerability, pathogenesis, and Parkinson's disease.

Authors:  David Sulzer; D James Surmeier
Journal:  Mov Disord       Date:  2013-04-15       Impact factor: 10.338

5.  Prevalence of hearing loss and differences by demographic characteristics among US adults: data from the National Health and Nutrition Examination Survey, 1999-2004.

Authors:  Yuri Agrawal; Elizabeth A Platz; John K Niparko
Journal:  Arch Intern Med       Date:  2008-07-28

Review 6.  DNA damage and its links to neurodegeneration.

Authors:  Ram Madabhushi; Ling Pan; Li-Huei Tsai
Journal:  Neuron       Date:  2014-07-16       Impact factor: 17.173

Review 7.  Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight.

Authors:  Aashiq Hussain Bhat; Khalid Bashir Dar; Suhail Anees; Mohammad Afzal Zargar; Akbar Masood; Manzoor Ahmad Sofi; Showkat Ahmad Ganie
Journal:  Biomed Pharmacother       Date:  2015-08-07       Impact factor: 6.529

Review 8.  Melanin and neuromelanin binding of drugs and chemicals: toxicological implications.

Authors:  Oskar Karlsson; Nils Gunnar Lindquist
Journal:  Arch Toxicol       Date:  2016-06-16       Impact factor: 5.153

Review 9.  Neuromelanin, one of the most overlooked molecules in modern medicine, is not a spectator.

Authors:  Robert L Haining; Cindy Achat-Mendes
Journal:  Neural Regen Res       Date:  2017-03       Impact factor: 5.135

Review 10.  Emerging Roles of Complement Protein C1q in Neurodegeneration.

Authors:  Kyoungjoo Cho
Journal:  Aging Dis       Date:  2019-06-01       Impact factor: 6.745

View more
  5 in total

Review 1.  Neuromelanin in Parkinson's Disease: Tyrosine Hydroxylase and Tyrosinase.

Authors:  Toshiharu Nagatsu; Akira Nakashima; Hirohisa Watanabe; Shosuke Ito; Kazumasa Wakamatsu
Journal:  Int J Mol Sci       Date:  2022-04-10       Impact factor: 6.208

Review 2.  Noradrenaline in Alzheimer's Disease: A New Potential Therapeutic Target.

Authors:  Irene L Gutiérrez; Cinzia Dello Russo; Fabiana Novellino; Javier R Caso; Borja García-Bueno; Juan C Leza; José L M Madrigal
Journal:  Int J Mol Sci       Date:  2022-05-30       Impact factor: 6.208

3.  Comparison of Different Tissue Clearing Methods for Three-Dimensional Reconstruction of Human Brain Cellular Anatomy Using Advanced Imaging Techniques.

Authors:  Marina Scardigli; Luca Pesce; Niamh Brady; Giacomo Mazzamuto; Vladislav Gavryusev; Ludovico Silvestri; Patrick R Hof; Christophe Destrieux; Irene Costantini; Francesco S Pavone
Journal:  Front Neuroanat       Date:  2021-11-11       Impact factor: 3.856

4.  Changes in cytoplasmic and extracellular neuromelanin in human substantia nigra with normal aging.

Authors:  Dmitrii E Korzhevskii; Olga V Kirik; Valeriia V Guselnikova; Darya L Tsyba; Elena A Fedorova; Igor P Grigorev
Journal:  Eur J Histochem       Date:  2021-09-01       Impact factor: 3.188

Review 5.  Antioxidant for Neurological Diseases and Neurotrauma and Bioengineering Approaches.

Authors:  Nasera Rizwana; Vipul Agarwal; Manasa Nune
Journal:  Antioxidants (Basel)       Date:  2021-12-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.